Research Article
Extracellular HMGB1 Induced Glomerular Endothelial Cell Injury via TLR4/MyD88 Signaling Pathway in Lupus Nephritis
Figure 6
Inhibition of the TLR4/MyD88/NF-κB/p65 pathway relieved GEC injury in HMGB1-induced LN. (a) Western blotting showed the expression of TLR4, NF-κB/p65, p-IκBα, and MyD88 in HRGECs cultured with LN plasma. (b) IF staining for NF-κB/p65 (red) in HRGECs cultured with LN plasma. (c, e, g, and h) Western blotting of TLR4, MyD88, and p-IκBα in LN plasma-stimulated HRGECs pretreated with different inhibitors. (d, f, and i) IF staining of NF-κB/p65 (red) in LN plasma-stimulated HRGECs pretreated with different inhibitors. (j, k) TEER and permeation in LN plasma-stimulated HRGECs pretreated with different inhibitors (, ). (l) The level of SDC-1 in supernatant of LN plasma-stimulated HRGECs pretreated with different inhibitors measured by ELISA. (m) IF staining of SDC-1 in LN plasma-stimulated HRGECs pretreated with different inhibitors. (n) IF staining of VE-cadherin (green) and F-actin (red) in LN plasma-stimulated HRGECs pretreated with different inhibitors. (o–q) Western blotting of VCAM-1 in LN plasma-stimulated HRGECs pretreated with different inhibitors. (r) The level of NO in LN plasma-stimulated HRGECs pretreated with different inhibitors. vs. control group; # vs. LN group.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |
(j) |
(k) |
(l) |
(m) |
(n) |
(o) |
(p) |
(q) |
(r) |